Certíková Chábová Vera, Kramer Herbert J, Vanecková Ivana, Thumová Monika, Skaroupková Petra, Tesar Vladimír, Falck John R, Imig John D, Cervenka Ludek
Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Kidney Blood Press Res. 2007;30(5):335-46. doi: 10.1159/000107710. Epub 2007 Aug 30.
The present study was performed in hypertensive Ren-2 transgenic rats (TGR) and in normotensive Hannover Sprague-Dawley (HanSD) rats. First, the intrarenal protein expression of CYP4A, the enzyme catalyzing the formation of 20-hydroxyeicosatetraenoic acid (20-HETE), and of CYP2C23, the enzyme responsible for epoxyeicosatrienoic acid (EET) production, was evaluated. Second, the renal functional responses to inhibition of the intrarenal formation of 20-HETE and EETs were investigated.
Renal hemodynamics and electrolyte excretion were evaluated in response to the administration of inhibitors of 20-HETE and EET formation into the renal artery. In renal cortical tissue, CYP4A and CYP2C23 protein expression was assessed by Western blot analysis. Urinary concentrations of 20-HETE and EETs were measured using a fluorescent HPLC assay.
TGR have higher kidney CYP4A protein expression and urinary 20-HETE excretion but significantly lower CYP2C23 protein expression and urinary EET excretion than HanSD. Intrarenal inhibition of 20-HETE and EET formation decreased sodium excretion in HanSD, whereas inhibition of 20-HETE increased urinary excretion of sodium in TGR without altering renal hemodynamics.
Our data suggest that in TGR, deficient intrarenal synthesis of EETs combined with increased synthesis of 20-HETE with its stimulation of tubular sodium absorption may contribute to the development of hypertension in TGR.
本研究在高血压的Ren-2转基因大鼠(TGR)和正常血压的汉诺威-斯普拉格-道利(HanSD)大鼠中进行。首先,评估了催化20-羟基二十碳四烯酸(20-HETE)形成的细胞色素P450 4A(CYP4A)以及负责环氧二十碳三烯酸(EET)生成的细胞色素P450 2C23(CYP2C23)的肾内蛋白表达。其次,研究了肾内20-HETE和EET生成受抑制时的肾功能反应。
通过向肾动脉注射20-HETE和EET生成抑制剂来评估肾血流动力学和电解质排泄。采用蛋白质免疫印迹分析评估肾皮质组织中CYP4A和CYP2C23的蛋白表达。使用荧光高效液相色谱法测定尿液中20-HETE和EET的浓度。
与HanSD相比,TGR的肾脏CYP4A蛋白表达和尿20-HETE排泄更高,但CYP2C23蛋白表达和尿EET排泄显著更低。肾内抑制20-HETE和EET生成可降低HanSD的钠排泄,而抑制20-HETE可增加TGR的尿钠排泄,且不改变肾血流动力学。
我们的数据表明,在TGR中,肾内EET合成不足,同时20-HETE合成增加并刺激肾小管钠重吸收,可能导致TGR发生高血压。